<SEC-DOCUMENT>0001144204-14-073812.txt : 20141215
<SEC-HEADER>0001144204-14-073812.hdr.sgml : 20141215
<ACCEPTANCE-DATETIME>20141215060746
ACCESSION NUMBER:		0001144204-14-073812
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20140901
FILED AS OF DATE:		20141215
DATE AS OF CHANGE:		20141215

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stellar Biotechnologies, Inc.
		CENTRAL INDEX KEY:			0001540159
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0831

	BUSINESS ADDRESS:	
		STREET 1:		332 EAST SCOTT STREET
		CITY:			PORT HUENEME
		STATE:			CA
		ZIP:			93041
		BUSINESS PHONE:		(805) 488-2800

	MAIL ADDRESS:	
		STREET 1:		332 EAST SCOTT STREET
		CITY:			PORT HUENEME
		STATE:			CA
		ZIP:			93041

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			OAKES FRANK R.
		CENTRAL INDEX KEY:			0001620188

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54598
		FILM NUMBER:		141284988

	MAIL ADDRESS:	
		STREET 1:		C/O STELLAR BIOTECHNOLOGIES, INC.
		STREET 2:		332 EAST SCOTT STREET
		CITY:			PORT HUENEME
		STATE:			CA
		ZIP:			93041
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>v396481_3a.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2014-09-01</periodOfReport>

    <dateOfOriginalSubmission>2014-09-26</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001540159</issuerCik>
        <issuerName>Stellar Biotechnologies, Inc.</issuerName>
        <issuerTradingSymbol>SBOTF</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001620188</rptOwnerCik>
            <rptOwnerName>OAKES FRANK R.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O STELLAR BIOTECHNOLOGIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>332 EAST SCOTT STREET</rptOwnerStreet2>
            <rptOwnerCity>PORT HUENEME</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>93041</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See Remarks</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Shares, without par value</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1967646</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Call Option (Obligation to Sell)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.25</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2012-11-26</value>
            </exerciseDate>
            <expirationDate>
                <value>2015-11-25</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>600000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Call Option (Obligation to Sell)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.25</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2012-11-26</value>
            </exerciseDate>
            <expirationDate>
                <value>2015-11-25</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>900000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The purpose of this amendment is to adjust the number of common shares beneficially owned by the reporting person as reported in Table I, Column 2, on the Form 3 filed on behalf of the reporting person on September 26, 2014 to reflect two call option agreements that were inadvertently omitted from Table II in the initial filing. In accordance with Instruction 5(c) to Form 3, the obligation to sell these securities is reported in Table II, with a corresponding adjustment to the number of shares originally reported as beneficially owned under Table I.</footnote>
    </footnotes>

    <remarks>President, Chief Executive Officer, and Director</remarks>

    <ownerSignature>
        <signatureName>/s/ Kathi Niffenegger, as Attorney in Fact</signatureName>
        <signatureDate>2014-12-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
